Immediate Impact
52 standout
Citing Papers
Radiotherapy toxicities: mechanisms, management, and future directions
2025 Standout
Multi drug resistance in Colorectal Cancer- approaches to overcome, advancements and future success
2024 Standout
Works of Steve Kelly being referenced
A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab
2012
Radiation pneumonitis in patients treated for breast cancer
1985
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Steve Kelly | 248 | 229 | 114 | 140 | 12 | 485 | |
| P. B. Kunkler | 203 | 100 | 88 | 188 | 15 | 531 | |
| P. Dickinson | 203 | 205 | 134 | 98 | 21 | 456 | |
| C. Terhaard | 378 | 257 | 65 | 98 | 20 | 557 | |
| Markus Glatzer | 186 | 170 | 64 | 96 | 32 | 445 | |
| João Luís Fernandes da Silva | 184 | 106 | 110 | 92 | 27 | 462 | |
| Lora S. Wang | 185 | 172 | 130 | 36 | 12 | 459 | |
| Gregg E. Franklin | 285 | 100 | 86 | 165 | 10 | 548 | |
| Tanja Pelz | 149 | 153 | 91 | 73 | 16 | 547 | |
| Elise Hasler | 279 | 114 | 105 | 123 | 21 | 522 | |
| Fábio Almeida | 267 | 118 | 75 | 263 | 19 | 448 |
All Works
Loading papers...